Literature DB >> 11673252

Gene transfer of prepro-calcitonin gene-related peptide restores erectile function in the aged rat.

T J Bivalacqua1, H C Champion, A B Abdel-Mageed, P J Kadowitz, W J Hellstrom.   

Abstract

Erectile dysfunction in the aging male is caused, in part, by inadequate relaxation of the corpora cavernosal smooth musculature. Calcitonin gene-related peptide (CGRP), a peptide neurotrasmitter localized in the corpora cavernosa, is down-regulated in the aging rat penis. We examined the hypothesis that this reduction in CGRP may contribute to decreased cavernosal smooth muscle relaxation. Therefore, we sought to determine whether adenoviral-mediated gene transfer of prepro-CGRP (AdRSVCGRP) could enhance erectile responses in aged rats. We found a significant decrease in CGRP concentrations and in cAMP and cGMP levels in aged rat cavernosal tissue compared to younger rats. Aged rats also had significantly lower erectile function as determined by cavernosal nerve stimulation compared to younger rats. Five days after transfection with AdRSVCGRP, these aged rats had an approximately threefold increase in cavernosal CGRP levels compared to animals transfected with adenoviruses encoding nuclear-targeted beta-galactosidase (AdRSV beta gal). The AdRSVCGRP-transfected animals also demonstrated an increase in CGRP mRNA and immunohistochemical localization of CGRP in the smooth muscle of the corpora cavernosa. In addition, cAMP levels in the corpora cavernosa were significantly increased, whereas cGMP levels remained unchanged. Adenoviral transduction efficiency of beta-galactosidase reporter gene was measured by chemiluminescence and was observed in cavernosal tissue 5 days after transfection with AdRSV beta gal. More importantly, 5 days after administration of AdRSVCGRP, a significant increase was observed in the erectile response to cavernosal nerve stimulation in the aged rat, similar to the response observed in younger rats. These data suggest that in vivo adenoviral gene transfer of CGRP can physiologically improve erectile function in the aged rat.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11673252     DOI: 10.1095/biolreprod65.5.1371

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  14 in total

Review 1.  Therapy of erectile dysfunction: potential future treatments.

Authors:  Nestor F Gonzalez-Cadavid; Jacob Rajfer
Journal:  Endocrine       Date:  2004 Mar-Apr       Impact factor: 3.633

Review 2.  Molecular mechanisms of detrusor and corporal myocyte contraction: identifying targets for pharmacotherapy of bladder and erectile dysfunction.

Authors:  George J Christ; Steve Hodges
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

Review 3.  Emerging and novel therapeutic approaches in the treatment of male erectile dysfunction.

Authors:  Eric Chung; Gerald B Brock
Journal:  Curr Urol Rep       Date:  2011-12       Impact factor: 3.092

Review 4.  Emerging tools for erectile dysfunction: a role for regenerative medicine.

Authors:  Lukman Hakim; Frank Van der Aa; Trinity J Bivalacqua; Petter Hedlund; Maarten Albersen
Journal:  Nat Rev Urol       Date:  2012-07-24       Impact factor: 14.432

5.  Neuroregenerative strategies after radical prostatectomy.

Authors:  Robert C Dean; Tom F Lue
Journal:  Rev Urol       Date:  2005

Review 6.  Emerging gene and stem cell therapies for the treatment of erectile dysfunction.

Authors:  Ahmed Harraz; Alan W Shindel; Tom F Lue
Journal:  Nat Rev Urol       Date:  2010-02-16       Impact factor: 14.432

Review 7.  An update on new oral PDE5 inhibitors for the treatment of erectile dysfunction.

Authors:  Victor Palit; Ian Eardley
Journal:  Nat Rev Urol       Date:  2010-11       Impact factor: 14.432

8.  Role of the nitric oxide pathway and the endocannabinoid system in neurogenic relaxation of corpus cavernosum from biliary cirrhotic rats.

Authors:  M Ghasemi; H Sadeghipour; H Shafaroodi; B G Nezami; T Gholipour; A R Hajrasouliha; S Tavakoli; M Nobakht; K P Moore; A R Mani; A R Dehpour
Journal:  Br J Pharmacol       Date:  2007-05-08       Impact factor: 8.739

9.  Analysis of erectile responses to BAY 41-8543 and muscarinic receptor stimulation in the rat.

Authors:  George F Lasker; Edward A Pankey; Alexander V Allain; Jasdeep S Dhaliwal; Johannes-Peter Stasch; Subramanyam N Murthy; Philip J Kadowitz
Journal:  J Sex Med       Date:  2012-09-18       Impact factor: 3.802

Review 10.  Looking to the future for erectile dysfunction therapies.

Authors:  Konstantinos Hatzimouratidis; Dimitrios G Hatzichristou
Journal:  Drugs       Date:  2008       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.